CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 265 filers reported holding CONMED CORP in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $519,680 | -25.8% | 5,153 | 0.0% | 0.07% | -26.0% |
| Q2 2023 | $700,241 | +7.6% | 5,153 | -17.8% | 0.10% | +1.1% |
| Q1 2023 | $650,891 | +164682.5% | 6,267 | +40.8% | 0.10% | +66.7% |
| Q4 2022 | $395 | -99.9% | 4,451 | +0.3% | 0.06% | -1.7% |
| Q3 2022 | $356,000 | -21.9% | 4,438 | -6.8% | 0.06% | -17.1% |
| Q2 2022 | $456,000 | -35.5% | 4,762 | 0.0% | 0.07% | -25.5% |
| Q1 2022 | $707,000 | +4.7% | 4,762 | 0.0% | 0.09% | +9.3% |
| Q4 2021 | $675,000 | +12.1% | 4,762 | +3.5% | 0.09% | -1.1% |
| Q3 2021 | $602,000 | -1.3% | 4,603 | +3.8% | 0.09% | +2.4% |
| Q2 2021 | $610,000 | -11.3% | 4,435 | -15.8% | 0.08% | -15.0% |
| Q1 2021 | $688,000 | +10.4% | 5,269 | -5.3% | 0.10% | +4.2% |
| Q4 2020 | $623,000 | +94.1% | 5,566 | +36.2% | 0.10% | +60.0% |
| Q3 2020 | $321,000 | – | 4,086 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 190,000 | $24,858,000 | 3.57% |
| Ranger Investment Management | 253,789 | $33,203,000 | 1.77% |
| EARNEST PARTNERS LLC | 1,603,130 | $209,737,000 | 1.28% |
| Penn Capital Management Company, LLC | 92,086 | $12,048,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,492,419 | $195,253,000 | 0.94% |
| MOODY ALDRICH PARTNERS LLC | 53,257 | $6,968,000 | 0.88% |
| Hood River Capital Management LLC | 215,384 | $28,179,000 | 0.87% |
| OAK RIDGE INVESTMENTS LLC | 71,880 | $9,404,000 | 0.83% |
| WAFRA INC. | 138,542 | $18,125,000 | 0.66% |
| EPIQ PARTNERS, LLC | 10,463 | $1,369,000 | 0.63% |